These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898 [TBL] [Abstract][Full Text] [Related]
5. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease. Dickson TC; King CE; McCormack GH; Vickers JC Exp Neurol; 1999 Mar; 156(1):100-10. PubMed ID: 10192781 [TBL] [Abstract][Full Text] [Related]
6. Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer's disease pathogenesis. D'Andrea MR; Nagele RG Biotech Histochem; 2010 Apr; 85(2):133-47. PubMed ID: 20121465 [TBL] [Abstract][Full Text] [Related]
7. MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer's disease. D'Andrea MR; Nagele RG Biotech Histochem; 2002 Mar; 77(2):95-103. PubMed ID: 12083391 [TBL] [Abstract][Full Text] [Related]
8. Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease. Grutzendler J; Helmin K; Tsai J; Gan WB Ann N Y Acad Sci; 2007 Feb; 1097():30-9. PubMed ID: 17413007 [TBL] [Abstract][Full Text] [Related]
9. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. Dickson TC; Vickers JC Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304 [TBL] [Abstract][Full Text] [Related]
10. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397 [TBL] [Abstract][Full Text] [Related]
11. Regression stage senile plaques in the natural course of Alzheimer's disease. Oide T; Kinoshita T; Arima K Neuropathol Appl Neurobiol; 2006 Oct; 32(5):539-56. PubMed ID: 16972888 [TBL] [Abstract][Full Text] [Related]
12. Microtubular reorganization and dendritic growth response in Alzheimer's disease. McKee AC; Kowall NW; Kosik KS Ann Neurol; 1989 Nov; 26(5):652-9. PubMed ID: 2817839 [TBL] [Abstract][Full Text] [Related]
13. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models. Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827 [TBL] [Abstract][Full Text] [Related]
14. Amyloid load and neural elements in Alzheimer's disease and nondemented individuals with high amyloid plaque density. Mochizuki A; Peterson JW; Mufson EJ; Trapp BD Exp Neurol; 1996 Nov; 142(1):89-102. PubMed ID: 8912901 [TBL] [Abstract][Full Text] [Related]
15. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury. Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957 [TBL] [Abstract][Full Text] [Related]
16. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites. Sasaki A; Shoji M; Harigaya Y; Kawarabayashi T; Ikeda M; Naito M; Matsubara E; Abe K; Nakazato Y Virchows Arch; 2002 Oct; 441(4):358-67. PubMed ID: 12404061 [TBL] [Abstract][Full Text] [Related]
18. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures. Brendza RP; O'Brien C; Simmons K; McKeel DW; Bales KR; Paul SM; Olney JW; Sanes JR; Holtzman DM J Comp Neurol; 2003 Feb; 456(4):375-83. PubMed ID: 12532409 [TBL] [Abstract][Full Text] [Related]
19. In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics. Esler WP; Stimson ER; Ghilardi JR; Vinters HV; Lee JP; Mantyh PW; Maggio JE Biochemistry; 1996 Jan; 35(3):749-57. PubMed ID: 8547255 [TBL] [Abstract][Full Text] [Related]
20. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy. Schmidt ML; Robinson KA; Lee VM; Trojanowski JQ Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]